title: In vitro growth inhibition of growth factor-stimulated meningioma cells by calcium channel antagonists.
abstract: Studies have shown that a majority of meningiomas contain receptors for platelet-derived growth factor and epidermal growth factor and that these growth factors promote the proliferation of meningioma cells in culture. Although the mechanism of action has not been elucidated, intracellular calcium appears to be part of the signal transduction mechanism. Because alterations in intracellular calcium could interrupt this pathway and decrease cellular proliferation, we investigated the effects of calcium channel-blocking agents on the growth of meningioma cells in vitro. Primary meningioma cell cultures were established, and the cells were characterized by light and electron microscopy and by immunohistochemical studies. Then, the cultures were given growth factors and/or various calcium channel antagonists, and growth rates were measured. A dose-response decrease in cell growth was seen when verapamil, nifedipine, or diltiazem (voltage-dependent calcium channel-blocking agents) was added to serum-containing media. Also, these drugs blocked the growth stimulation of epidermal growth factor and platelet-derived growth factor in a similar fashion. Dantrolene, which inhibits the release of sequestered intracellular calcium, was also an effective blocker of the mitogenic stimulation of these growth factors.
authors.affiliation: Department of Neurological Surgery, Loyola University, Maywood, Illinois, USA.
authors.forename: R L
authors.initials: RL
authors.lastname: Jensen
authors.forename: T C
authors.initials: TC
authors.lastname: Origitano
authors.forename: Y S
authors.initials: YS
authors.lastname: Lee
authors.forename: M
authors.initials: M
authors.lastname: Weber
authors.forename: R D
authors.initials: RD
authors.lastname: Wurster
mesh_terms: D000328:Adult; D000368:Aged; D001790:Blood Physiological Phenomena; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D002455:Cell Division / Q000187:drug effects / Q000502:physiology; D004815:Epidermal Growth Factor / Q000494:pharmacology*; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008577:Meningeal Neoplasms / Q000473:pathology*; D008579:Meningioma / Q000473:pathology*; D008854:Microscopy, Electron; D008875:Middle Aged; D010982:Platelet-Derived Growth Factor / Q000494:pharmacology*; D014407:Tumor Cells, Cultured
chemical_list: D002121:Calcium Channel Blockers; D010982:Platelet-Derived Growth Factor; D004815:Epidermal Growth Factor